As a rare condition that causes gradual worsening of symptoms concerning movement, speech, memory, and swallowing, corticobasal degeneration affects 5 in 100,000 people in the US every year.
Because the symptoms of this condition are very similar to those of Parkinson's, misdiagnosis can easily occur.
Individuals with a history of exposure to paraquat need to seek a second or even a third opinion.
Paraquat exposure is associated with a 250% higher risk of developing Parkinson's disease in agricultural workers since they are frequently working with this herbicide. The good news is that they can now recover financial compensation for their disease from the liable paraquat manufacturers with the help of a team of professionals.
Usually, the symptoms of corticobasal degeneration worsen over time in frequency and intensity. Numerous symptoms of this condition are very similar to those of Parkinson's disease, which is why people who are at risk of developing the latter need to keep a close eye on their health and be examined by multiple specialists in order to receive the right diagnosis. The following symptoms are the most common in people with corticobasal degeneration:
It is worthy of note that the symptoms of corticobasal degeneration initially affect one side of the body more than the other, as well as that this condition is a type of parkinsonism, which is another factor that makes accurate diagnosis challenging for medical professionals. Nevertheless, corticobasal degeneration is a different condition than Parkinson's disease, and doctors need to keep this crucial aspect in mind when assessing the health and symptoms of a patient.
Since the symptoms of corticobasal degeneration resemble those of Parkinson's disease, assigning a correct diagnosis is difficult in spite of the existence of certain typical clinical features. A very effective test in this respect is single-photon emission computed tomography, which, in people with corticobasal degeneration, presents original patterns that could facilitate differential diagnosis.
The most discriminating regions of interest of the brain of people with corticobasal degeneration and individuals with Parkinson's disease were the temporoinsular, frontal medial, and temporoparietal areas.
Accordingly, these regions of the brain respond differently in people with corticobasal degeneration than in those with Parkinson's disease. Medical researchers believe that photon emission computed tomography may be a precious tool for reinforcing the current clinical differential diagnosis of corticobasal degeneration and Parkinson's disease.
Atraxia Law has over 35 years of experience in evaluating personal injury and product liability claims, and our team of experts is ready to provide you with the assistance you need to find out whether you are eligible for filing a paraquat exposure claim.
To become eligible to file a claim, you must have a diagnosis of Parkinson's disease and must have worked with paraquat for a long period of time.